During the past decade, Interchange General Practice conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Interchange General Practice" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Diagnostic Technology" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Interchange General Practice" are "HIV" (1 trials), "HIV Infection" (1 trials), "Influenza and Other Novel Respiratory Viruses" (1 trials) and "STI" (1 trials). Many other conditions were trialed in "Interchange General Practice" in a lesser frequency.

Most popular intervention types in "Interchange General Practice" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "HIV drug resistance tests based upon genotype testing" (1 trials) and "TDF/FTC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Interchange General Practice" are 2 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Interchange General Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Interchange General Practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Interchange General Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".